SlidesetHIVA Multicenter Observational Study on the Efficacy and Tolerability of Dolutegravir combined with Tenofovir/Emtricitabine or Abacavir/Lamivudine as a Switch Strategy for HIV-1 Pos. ART-exp. Patients with Stable Viral Suppression- Alberto BorghettiView Slideset
SlidesetHIVImpact on: Pharmacology – penetration to sanctuary sites and drug-drug interactions - Courtney Fletcher, PharmDView Slideset
SlidesetHIVVirological failure even at low levels of viremia can be associated to integrase strand-transfer inhibitors resistance in HIV-1 infected patients - Benet GarrabéView Slideset
SlidesetHIVFrench National survey of resistance to integrase inhibitors shows high differences of resistance selection rate in case of virological failure in a context of routine hospital care (ANRS AC11 virology network) - Vincent CalvezView Slideset
SlidesetHIVAn Italian case of transmitted integrase inhibitor resistance in a drug-naïve patient: a refined analysis by ultra-deep-454 pyrosequencing - Ada BertoliView Slideset
SlidesetHIVClinical Case Presentations – How to manage drug - drug interactions - the practice - Anna Maria Geretti, MD, PhD, FRCPathView Slideset
SlidesetHIVClinical Utility of Integrase Inhibitors during pregnancy - Saye Khoo, MD, PhDView Slideset
SlidesetHIVVirological response of HIV-infected-patients virologically-suppressed switching to a DTG-based regimen in an observational cohort based on the genotypic susceptibility score - Diane DescampsView Slideset
SlidesetHIVLamivudine plus either Atazanavir/ritonavir, Darunavir/ritonavir or Dolutegravir as switch strategies in HIV-positive, virologically-suppressed patients: a comparison - Alberto BorghettiView Slideset
SlidesetHIVSwitching from combination antiretroviral therapy (cART) to dolutegravir (DTG) monotherapy in virologically suppressed HIV-1 infected adults: a randomized multicenter, non-inferiority clinical trial (DOMONO) - Ingeborg WijtingView Slideset
SlidesetHIVInduction-Maintenance ARV Therapy: Why, Who, When and How? - Pedro Cahn, MD, PhDView Slideset
SlidesetHIVClinical Case Presentations - Experience with Induction-Maintenance Therapy in real life settings - José Arribas, MDView Slideset
SlidesetHIVMaintenance Therapy with Dolutegravir/Rilpivirin is efficient and well tolerated in a real-life setting - Katharina Grabmeijer PfistershammerView Slideset
SlidesetHIVHow to manage drug - drug interactions - the theory - Giovanni Di Perri, MD, PhDView Slideset
